{"transactions":[{"id":1501622,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T19:14:30.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":10.3,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-24-064810","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000095017024064810/ownership.xml","form_type":"4"}},{"id":1501621,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T19:14:30.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 23, 2024, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":19500,"source":{"system":"sec-edgar","filing":"0000950170-24-064810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000095017024064810/ownership.xml","form_type":"4"}},{"id":1874347,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T18:57:57.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":11.72,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919123033020/doc4.xml","form_type":"4"}},{"id":1874346,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T18:57:57.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 25, 2023, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-23-033020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919123033020/doc4.xml","form_type":"4"}},{"id":2252860,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T16:47:26.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":7.4,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-032586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919122032586/doc4.xml","form_type":"4"}},{"id":2545318,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T18:28:55.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":2529,"price":32.049,"value":81051.921,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.82 to\t$32.58. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1211346,"source":{"system":"sec-edgar","filing":"0001209191-21-060109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121060109/doc4.xml","form_type":"4"}},{"id":2545317,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T18:28:55.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":15471,"price":32.6639,"value":505343.1969,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $33.16. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1213875,"source":{"system":"sec-edgar","filing":"0001209191-21-060109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121060109/doc4.xml","form_type":"4"}},{"id":2560705,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:37:13.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":4100,"price":32.06,"value":131446.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $32.57. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1229346,"source":{"system":"sec-edgar","filing":"0001209191-21-057517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121057517/doc4.xml","form_type":"4"}},{"id":2560704,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:37:13.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":324,"price":33.3058,"value":10791.0792,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.23 to $33.36. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1233446,"source":{"system":"sec-edgar","filing":"0001209191-21-057517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121057517/doc4.xml","form_type":"4"}},{"id":2560703,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:37:13.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":13576,"price":32.7868,"value":445113.5968,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.1650. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1233770,"source":{"system":"sec-edgar","filing":"0001209191-21-057517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121057517/doc4.xml","form_type":"4"}},{"id":2597434,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-18T17:31:06.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":13791,"price":31.4907,"value":434288.2437,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.80.The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1247346,"source":{"system":"sec-edgar","filing":"0001209191-21-052287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121052287/doc4.xml","form_type":"4"}},{"id":2597433,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-18T17:31:06.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":4209,"price":30.4704,"value":128249.9136,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.98. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total number of outstanding shares reflects an increase of 4,401 shares to correct an arithmetic error in the total number of shares initially reported on his Form 4 filed on November 9, 2020."}],"balance_after":1261137,"source":{"system":"sec-edgar","filing":"0001209191-21-052287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121052287/doc4.xml","form_type":"4"}},{"id":2651342,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-29T20:43:44.000Z","date":"2021-06-29","kind":"sale","acquired":false,"shares":13960,"price":34.0012,"value":474656.752,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.85 to $34.77. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1260945,"source":{"system":"sec-edgar","filing":"0001209191-21-043851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121043851/doc4.xml","form_type":"4"}},{"id":2651341,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-29T20:43:44.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":156,"price":35.0869,"value":5473.5564,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.86 to $35.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1274905,"source":{"system":"sec-edgar","filing":"0001209191-21-043851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121043851/doc4.xml","form_type":"4"}},{"id":2651340,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-29T20:43:44.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":25884,"price":34.0678,"value":881810.9352,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.85 to $34.83. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1275061,"source":{"system":"sec-edgar","filing":"0001209191-21-043851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121043851/doc4.xml","form_type":"4"}},{"id":2698348,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T17:35:14.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Registrant's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Registrant's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":35.49,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-035466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035466/doc4.xml","form_type":"4"}},{"id":2700466,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T18:13:37.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":305,"price":35.2662,"value":10756.191,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.23 to $35.41. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1300945,"source":{"system":"sec-edgar","filing":"0001209191-21-035068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035068/doc4.xml","form_type":"4"}},{"id":2700465,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T18:13:37.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":2278,"price":34.934,"value":79579.652,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.23 to $35.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1301250,"source":{"system":"sec-edgar","filing":"0001209191-21-035068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035068/doc4.xml","form_type":"4"}},{"id":2700464,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T18:13:37.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":899,"price":33.7606,"value":30350.7794,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $34.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1303528,"source":{"system":"sec-edgar","filing":"0001209191-21-035068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035068/doc4.xml","form_type":"4"}},{"id":2700463,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T18:13:37.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":3229,"price":33.3796,"value":107782.7284,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.32 to $33.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1304427,"source":{"system":"sec-edgar","filing":"0001209191-21-035068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035068/doc4.xml","form_type":"4"}},{"id":2700462,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T18:13:37.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":16020,"price":32.7836,"value":525193.272,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.30 to $33.28. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1307656,"source":{"system":"sec-edgar","filing":"0001209191-21-035068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035068/doc4.xml","form_type":"4"}},{"id":2700461,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T18:13:37.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":17269,"price":31.9557,"value":551842.9833,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.29 to $32.28. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1323676,"source":{"system":"sec-edgar","filing":"0001209191-21-035068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121035068/doc4.xml","form_type":"4"}},{"id":2753971,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":6795,"price":38.0302,"value":258415.209,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.74 to $38.35. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1340945,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2753970,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":6328,"price":37.3738,"value":236501.4064,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.74 to $37.73. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1347740,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2753969,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":3359,"price":35.9698,"value":120822.5582,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.65 to $36.60. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1354068,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2753968,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":1400,"price":34.9605,"value":48944.7,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.55 to $35.37. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1357427,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2753967,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":1730,"price":37.1532,"value":64275.036,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.02 to $37.59. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1358827,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2753966,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":7769,"price":36.4002,"value":282793.1538,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.02 to $37.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1360557,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2753965,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T16:13:34.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":12619,"price":35.6872,"value":450336.7768,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.02 to $36.01. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1368326,"source":{"system":"sec-edgar","filing":"0001209191-21-025856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121025856/doc4.xml","form_type":"4"}},{"id":2791358,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:54:40.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":500,"price":46.67,"value":23335.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"balance_after":1380945,"source":{"system":"sec-edgar","filing":"0001209191-21-020266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121020266/doc4.xml","form_type":"4"}},{"id":2791357,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:54:40.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":731,"price":47.5367,"value":34749.3277,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.50 to $47.67. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1381445,"source":{"system":"sec-edgar","filing":"0001209191-21-020266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121020266/doc4.xml","form_type":"4"}},{"id":2791356,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:54:40.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":41698,"price":47.1809,"value":1967349.1682,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1382176,"source":{"system":"sec-edgar","filing":"0001209191-21-020266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121020266/doc4.xml","form_type":"4"}},{"id":2791355,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:54:40.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":1802,"price":49.9303,"value":89974.4006,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.57 to $50.29. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1423874,"source":{"system":"sec-edgar","filing":"0001209191-21-020266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121020266/doc4.xml","form_type":"4"}},{"id":2791354,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:54:40.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":7844,"price":49.0203,"value":384515.2332,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.53 to $47.50. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1425676,"source":{"system":"sec-edgar","filing":"0001209191-21-020266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121020266/doc4.xml","form_type":"4"}},{"id":2791353,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:54:40.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":2425,"price":48.3163,"value":117167.0275,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.53 to $48.52. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1433520,"source":{"system":"sec-edgar","filing":"0001209191-21-020266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121020266/doc4.xml","form_type":"4"}},{"id":2838578,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":2084,"price":44.6967,"value":93147.9228,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.05 to $45.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1435945,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838577,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":1881,"price":43.3461,"value":81534.0141,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.90. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1438029,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838576,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":1019,"price":42.5018,"value":43309.3342,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1439910,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838575,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":1417,"price":46.9901,"value":66584.9717,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.81 to $47.35. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1440929,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838574,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":7241,"price":46.025,"value":333267.025,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.80 to $46.64. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1442346,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838573,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":11482,"price":45.2652,"value":519735.0264,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.76 to $45.755. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1449587,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838572,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":18316,"price":47.61,"value":872024.76,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.26 to $48.22. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1461069,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838571,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":21360,"price":47.0834,"value":1005701.424,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.26 to $47.25. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1479385,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2838570,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:14:36.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":5200,"price":46.0207,"value":239307.64,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.26 to $46.24. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1500745,"source":{"system":"sec-edgar","filing":"0001209191-21-013373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121013373/doc4.xml","form_type":"4"}},{"id":2862634,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T16:46:14.000Z","date":"2020-12-01","kind":"gift","acquired":false,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"balance_after":1505945,"source":{"system":"sec-edgar","filing":"0001209191-21-010174","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121010174/doc5.xml","form_type":"5"}},{"id":2908006,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-13T17:07:13.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":20091,"price":36.1845,"value":726982.7895,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.97 to $36.54. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1532945,"source":{"system":"sec-edgar","filing":"0001209191-21-003443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121003443/doc4.xml","form_type":"4"}},{"id":2908005,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-13T17:07:13.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":7074,"price":35.7382,"value":252812.0268,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.97 to $35.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1553036,"source":{"system":"sec-edgar","filing":"0001209191-21-003443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121003443/doc4.xml","form_type":"4"}},{"id":2908004,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-13T17:07:13.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":12835,"price":34.9235,"value":448243.1225,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.48 to $35.32. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1560110,"source":{"system":"sec-edgar","filing":"0001209191-21-003443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919121003443/doc4.xml","form_type":"4"}},{"id":2937473,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":100,"price":42,"value":4200.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"balance_after":1572945,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2937472,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":12915,"price":41.4302,"value":535071.033,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1573045,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2937471,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":35197,"price":40.4894,"value":1425105.4118,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1585960,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2937470,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":200,"price":48.99,"value":9798.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"balance_after":1621157,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2937469,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":12954,"price":48.19,"value":624253.26,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.74 to $48.71. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1621357,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2937468,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":13292,"price":47.3492,"value":629365.5664,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.74 to $47.7308. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1634311,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2937467,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T20:01:13.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":5000,"price":46.2205,"value":231102.5,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.72 to $46.70. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1647603,"source":{"system":"sec-edgar","filing":"0001209191-20-064565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120064565/doc4.xml","form_type":"4"}},{"id":2982858,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":903,"price":40.3605,"value":36445.5315,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $40.90. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1652603,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982857,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":3354,"price":39.224,"value":131557.296,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.71 to $39.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1653506,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982856,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":2620,"price":38.1747,"value":100017.714,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.71 to $38.70. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1656860,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982855,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":200,"price":43.07,"value":8614.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"balance_after":1659480,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982854,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":4601,"price":42.3114,"value":194674.7514,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.89 to $42.75. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1664081,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982853,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":7880,"price":41.2923,"value":325383.324,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.88. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1668682,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982852,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":100,"price":44,"value":4400.0,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"balance_after":1676562,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982851,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":5477,"price":42.6663,"value":233683.3251,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.36 to $43.29. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1676662,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}},{"id":2982850,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":90591,"kind":"person","name":"Socks David A","position":1,"cik":"0001378847","reported_name":"Socks David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T16:13:12.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":5207,"price":41.9478,"value":218422.1946,"ownership":{"direct":false,"nature":"David A. Socks 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.35 to $42.33. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 642 shares of common stock of the Issuer received by the Reporting Person in a pro-rata, distribution in-kind exempt under Rule 16a-9."}],"balance_after":1682139,"source":{"system":"sec-edgar","filing":"0001209191-20-057921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378847/000120919120057921/doc4.xml","form_type":"4"}}]}